The global Humanized Mouse and Rat Model market size was valued at US$ 107.8 million in 2023. With growing demand in downstream market, the Humanized Mouse and Rat Model is forecast to a readjusted size of US$ 179.3 million by 2030 with a CAGR of 7.5% during review period.
The research report highlights the growth potential of the global Humanized Mouse and Rat Model market. Humanized Mouse and Rat Model are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Humanized Mouse and Rat Model. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Humanized Mouse and Rat Model market.
A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of RandD activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
Key Features:
The report on Humanized Mouse and Rat Model market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Humanized Mouse and Rat Model market. It may include historical data, market segmentation by Type (e.g., Genetic, Cell-Based), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Humanized Mouse and Rat Model market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Humanized Mouse and Rat Model market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Humanized Mouse and Rat Model industry. This include advancements in Humanized Mouse and Rat Model technology, Humanized Mouse and Rat Model new entrants, Humanized Mouse and Rat Model new investment, and other innovations that are shaping the future of Humanized Mouse and Rat Model.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Humanized Mouse and Rat Model market. It includes factors influencing customer ' purchasing decisions, preferences for Humanized Mouse and Rat Model product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Humanized Mouse and Rat Model market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Humanized Mouse and Rat Model market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Humanized Mouse and Rat Model market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Humanized Mouse and Rat Model industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Humanized Mouse and Rat Model market.
Market Segmentation:
Humanized Mouse and Rat Model market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Genetic
Cell-Based
Segmentation by application
Pharmaceutical
Biotechnology Companies
CRO
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Humanized Mouse and Rat Model market?
What factors are driving Humanized Mouse and Rat Model market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humanized Mouse and Rat Model market opportunities vary by end market size?
How does Humanized Mouse and Rat Model break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Humanized Mouse and Rat Model Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Humanized Mouse and Rat Model by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Humanized Mouse and Rat Model by Country/Region, 2019, 2023 & 2030
2.2 Humanized Mouse and Rat Model Segment by Type
2.2.1 Genetic
2.2.2 Cell-Based
2.3 Humanized Mouse and Rat Model Sales by Type
2.3.1 Global Humanized Mouse and Rat Model Sales Market Share by Type (2019-2024)
2.3.2 Global Humanized Mouse and Rat Model Revenue and Market Share by Type (2019-2024)
2.3.3 Global Humanized Mouse and Rat Model Sale Price by Type (2019-2024)
2.4 Humanized Mouse and Rat Model Segment by Application
2.4.1 Pharmaceutical
2.4.2 Biotechnology Companies
2.4.3 CRO
2.5 Humanized Mouse and Rat Model Sales by Application
2.5.1 Global Humanized Mouse and Rat Model Sale Market Share by Application (2019-2024)
2.5.2 Global Humanized Mouse and Rat Model Revenue and Market Share by Application (2019-2024)
2.5.3 Global Humanized Mouse and Rat Model Sale Price by Application (2019-2024)
3 Global Humanized Mouse and Rat Model by Company
3.1 Global Humanized Mouse and Rat Model Breakdown Data by Company
3.1.1 Global Humanized Mouse and Rat Model Annual Sales by Company (2019-2024)
3.1.2 Global Humanized Mouse and Rat Model Sales Market Share by Company (2019-2024)
3.2 Global Humanized Mouse and Rat Model Annual Revenue by Company (2019-2024)
3.2.1 Global Humanized Mouse and Rat Model Revenue by Company (2019-2024)
3.2.2 Global Humanized Mouse and Rat Model Revenue Market Share by Company (2019-2024)
3.3 Global Humanized Mouse and Rat Model Sale Price by Company
3.4 Key Manufacturers Humanized Mouse and Rat Model Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humanized Mouse and Rat Model Product Location Distribution
3.4.2 Players Humanized Mouse and Rat Model Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Humanized Mouse and Rat Model by Geographic Region
4.1 World Historic Humanized Mouse and Rat Model Market Size by Geographic Region (2019-2024)
4.1.1 Global Humanized Mouse and Rat Model Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Humanized Mouse and Rat Model Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Humanized Mouse and Rat Model Market Size by Country/Region (2019-2024)
4.2.1 Global Humanized Mouse and Rat Model Annual Sales by Country/Region (2019-2024)
4.2.2 Global Humanized Mouse and Rat Model Annual Revenue by Country/Region (2019-2024)
4.3 Americas Humanized Mouse and Rat Model Sales Growth
4.4 APAC Humanized Mouse and Rat Model Sales Growth
4.5 Europe Humanized Mouse and Rat Model Sales Growth
4.6 Middle East & Africa Humanized Mouse and Rat Model Sales Growth
5 Americas
5.1 Americas Humanized Mouse and Rat Model Sales by Country
5.1.1 Americas Humanized Mouse and Rat Model Sales by Country (2019-2024)
5.1.2 Americas Humanized Mouse and Rat Model Revenue by Country (2019-2024)
5.2 Americas Humanized Mouse and Rat Model Sales by Type
5.3 Americas Humanized Mouse and Rat Model Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humanized Mouse and Rat Model Sales by Region
6.1.1 APAC Humanized Mouse and Rat Model Sales by Region (2019-2024)
6.1.2 APAC Humanized Mouse and Rat Model Revenue by Region (2019-2024)
6.2 APAC Humanized Mouse and Rat Model Sales by Type
6.3 APAC Humanized Mouse and Rat Model Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Humanized Mouse and Rat Model by Country
7.1.1 Europe Humanized Mouse and Rat Model Sales by Country (2019-2024)
7.1.2 Europe Humanized Mouse and Rat Model Revenue by Country (2019-2024)
7.2 Europe Humanized Mouse and Rat Model Sales by Type
7.3 Europe Humanized Mouse and Rat Model Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Humanized Mouse and Rat Model by Country
8.1.1 Middle East & Africa Humanized Mouse and Rat Model Sales by Country (2019-2024)
8.1.2 Middle East & Africa Humanized Mouse and Rat Model Revenue by Country (2019-2024)
8.2 Middle East & Africa Humanized Mouse and Rat Model Sales by Type
8.3 Middle East & Africa Humanized Mouse and Rat Model Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humanized Mouse and Rat Model
10.3 Manufacturing Process Analysis of Humanized Mouse and Rat Model
10.4 Industry Chain Structure of Humanized Mouse and Rat Model
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humanized Mouse and Rat Model Distributors
11.3 Humanized Mouse and Rat Model Customer
12 World Forecast Review for Humanized Mouse and Rat Model by Geographic Region
12.1 Global Humanized Mouse and Rat Model Market Size Forecast by Region
12.1.1 Global Humanized Mouse and Rat Model Forecast by Region (2025-2030)
12.1.2 Global Humanized Mouse and Rat Model Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Humanized Mouse and Rat Model Forecast by Type
12.7 Global Humanized Mouse and Rat Model Forecast by Application
13 Key Players Analysis
13.1 The Jackson Laboratory (US)
13.1.1 The Jackson Laboratory (US) Company Information
13.1.2 The Jackson Laboratory (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.1.3 The Jackson Laboratory (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 The Jackson Laboratory (US) Main Business Overview
13.1.5 The Jackson Laboratory (US) Latest Developments
13.2 Taconic Biosciences (US)
13.2.1 Taconic Biosciences (US) Company Information
13.2.2 Taconic Biosciences (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.2.3 Taconic Biosciences (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Taconic Biosciences (US) Main Business Overview
13.2.5 Taconic Biosciences (US) Latest Developments
13.3 Horizon Discovery Group(UK)
13.3.1 Horizon Discovery Group(UK) Company Information
13.3.2 Horizon Discovery Group(UK) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.3.3 Horizon Discovery Group(UK) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Horizon Discovery Group(UK) Main Business Overview
13.3.5 Horizon Discovery Group(UK) Latest Developments
13.4 genOway (France)
13.4.1 genOway (France) Company Information
13.4.2 genOway (France) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.4.3 genOway (France) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 genOway (France) Main Business Overview
13.4.5 genOway (France) Latest Developments
13.5 Charles River Laboratories (US)
13.5.1 Charles River Laboratories (US) Company Information
13.5.2 Charles River Laboratories (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.5.3 Charles River Laboratories (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Charles River Laboratories (US) Main Business Overview
13.5.5 Charles River Laboratories (US) Latest Developments
13.6 Harbour Antibodies BV (China)
13.6.1 Harbour Antibodies BV (China) Company Information
13.6.2 Harbour Antibodies BV (China) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.6.3 Harbour Antibodies BV (China) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Harbour Antibodies BV (China) Main Business Overview
13.6.5 Harbour Antibodies BV (China) Latest Developments
13.7 Hera BioLabs (US)
13.7.1 Hera BioLabs (US) Company Information
13.7.2 Hera BioLabs (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.7.3 Hera BioLabs (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hera BioLabs (US) Main Business Overview
13.7.5 Hera BioLabs (US) Latest Developments
13.8 Vitalstar Biotechnology Co (China)
13.8.1 Vitalstar Biotechnology Co (China) Company Information
13.8.2 Vitalstar Biotechnology Co (China) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.8.3 Vitalstar Biotechnology Co (China) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Vitalstar Biotechnology Co (China) Main Business Overview
13.8.5 Vitalstar Biotechnology Co (China) Latest Developments
13.9 inGenious Targeting Laboratory (US)
13.9.1 inGenious Targeting Laboratory (US) Company Information
13.9.2 inGenious Targeting Laboratory (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.9.3 inGenious Targeting Laboratory (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 inGenious Targeting Laboratory (US) Main Business Overview
13.9.5 inGenious Targeting Laboratory (US) Latest Developments
13.10 AXENIS(France)
13.10.1 AXENIS(France) Company Information
13.10.2 AXENIS(France) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.10.3 AXENIS(France) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AXENIS(France) Main Business Overview
13.10.5 AXENIS(France) Latest Developments
13.11 Crown Bioscience (US)
13.11.1 Crown Bioscience (US) Company Information
13.11.2 Crown Bioscience (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.11.3 Crown Bioscience (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Crown Bioscience (US) Main Business Overview
13.11.5 Crown Bioscience (US) Latest Developments
13.12 Transgenic (Japan)
13.12.1 Transgenic (Japan) Company Information
13.12.2 Transgenic (Japan) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.12.3 Transgenic (Japan) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Transgenic (Japan) Main Business Overview
13.12.5 Transgenic (Japan) Latest Developments
13.13 Champions Oncology (US)
13.13.1 Champions Oncology (US) Company Information
13.13.2 Champions Oncology (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.13.3 Champions Oncology (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Champions Oncology (US) Main Business Overview
13.13.5 Champions Oncology (US) Latest Developments
13.14 Horizon Discovery Group(UK)
13.14.1 Horizon Discovery Group(UK) Company Information
13.14.2 Horizon Discovery Group(UK) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.14.3 Horizon Discovery Group(UK) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Horizon Discovery Group(UK) Main Business Overview
13.14.5 Horizon Discovery Group(UK) Latest Developments
13.15 Hera BioLabs (US)
13.15.1 Hera BioLabs (US) Company Information
13.15.2 Hera BioLabs (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.15.3 Hera BioLabs (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hera BioLabs (US) Main Business Overview
13.15.5 Hera BioLabs (US) Latest Developments
13.16 Yecuris Corporation (US)
13.16.1 Yecuris Corporation (US) Company Information
13.16.2 Yecuris Corporation (US) Humanized Mouse and Rat Model Product Portfolios and Specifications
13.16.3 Yecuris Corporation (US) Humanized Mouse and Rat Model Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Yecuris Corporation (US) Main Business Overview
13.16.5 Yecuris Corporation (US) Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
